Ventis Pharma

Dental Division

A Novel Local Anesthetic Option for Dental Procedures

Endura-KT is a compounded local anesthetic formulation developed for dental practitioners seeking a non-opioid approach to procedural anesthesia and extended post-procedural patient comfort.

The formulation incorporates specific concentrations of tetracaine, lidocaine, and epinephrine identified during product development and intended to support procedural anesthesia and post-procedural patient management.

While tetracaine may be less familiar to some dental practitioners, it has been utilized in a variety of medical and dental applications. Tetracaine is a component of several marketed anesthetic products and formulations used in procedural settings.

Many clinicians report that Endura-KT supports an anesthesia experience characterized by the return of normal sensation in the lips, tongue, and facial tissues while maintaining comfort at the treatment site following procedures.

Endura-KT may be incorporated into a clinician’s overall multimodal pain management strategy based on individual patient needs and practitioner judgment.

Endura-KT combines

These pharmaceutical ingredients have a long history of use in dental and medical practice.

Why do clinicians consider

Clinicians utilizing Endura-KT have reported:

Rapid onset following administration
Return of normal facial sensation following treatment
Gradual transition as anesthetic effects diminish
Post-procedural comfort that may extend for 48-72+ hours in appropriate patients and procedures
Administration using familiar dental local anesthetic techniques, including infiltration and block anesthesia
Flexibility to administer before, during, or after a procedure based on clinical judgment

Use as a primary anesthetic or as an adjunct to existing anesthetic protocols
Use in conjunction with other local anesthetics when deemed appropriate by the treating practitioner
Interest from patients seeking non-opioid approaches to post-procedural comfort
Integration into multimodal pain management protocols focused on minimizing opioid exposure
A more comfortable injection experience, with little to no burning or stinging reported, which may be related to its pH range of 6.0-6.7

Important Disclosure Notice:

Endura-KT is a compounded preparation. Healthcare providers should evaluate each patient individually and determine appropriate use based on clinical judgment, procedure type, medical history, and treatment goals.

Endura-KT has not been evaluated by the FDA for safety or effectiveness. Statements regarding clinician experience reflect reported observations and should not be interpreted as guarantees of individual patient outcomes.

Procedures in which clinicians have reported utilizing

Examples of procedures for which clinicians have reported utilizing Endura-KT include:

Oral Surgery

Third molar surgery
Multiple extractions and alveoloplasty
Dry socket management
Biopsies
Frenectomies
Implant placement and uncovering
Socket preservation
Bone grafts
Full-arch implants and prosthetics

Periodontics

Endodontics

General Dentistry

Real life useage

Testimonials

58 year old emergency room doctor who had large abscess associated with a fractured root. Typically these patients need up to 7 days of pain meds due to the severity of the infection. Procedure: surgical extraction with agressive gingival curettage due to the subperiosteal infection. Placed bone graft and administered EnduraKT. Patient stated that she would love to use this on her patients because she didn't experience any post op pain and didn't need to take any pain meds following the procedure. She highly recommended that EnduraKT be the standard for post operative patient care.

50 year old famous author who had an implant placed with sinus lift procedure. Typically, these patients need 3-4 days of post op pain meds. Patient stated that he did not need any pain meds and he was able to go about his hectic day without rescheduling any meetings due to discomfort.

20 year old college student and professional surfer. Procedure: surgical removal of 4 wisdom teeth that involved cutting of soft tissue and hard tissue in order to remove. several sutures placed with collagen plugs. Patient only took the initial 800 mg of Ibuprofen not knowing what to expect once the LA wore off. He never needed any pain meds following that initial dose. He admitted to surfing the next day even though I advised not to.

All 3 patients (and the 20 year old's parents) stated that they were soooo happy that I used EnduraKT on them. The parents of the 20 year old said that they were most fearful of the meds needed following the procedure versus the procedure itself.

Meet the Team

Our Dental Team

Bettina Cantrell

President – Ventis Pharma Dental Division

Bettina Cantrell is a strategic commercial leader with more than 20 years of experience driving growth, innovation, and operational excellence across the dental industry globally. She brings a rare end-to-end perspective to dental healthcare, having worked across clinical operations, practice ownership, consulting, and senior executive leadership within some of the industry’s most respected organizations.

Most recently, as Senior Director of Strategic Accounts for ClearCorrect at Straumann Group in North America, Bettina led significant revenue growth through the Dental Service Organization (DSO) channel, building trusted partnerships with executive leadership teams and key opinion leaders. Her background includes senior leadership roles with Straumann Group (Australia and North America), Bupa Dental Corporation, Henry Schein, 3M, and the University of Newcastle, as well as ownership and management of private dental practices. Known for her collaborative leadership style and data-driven approach, Bettina is passionate about advancing innovative dental solutions, expanding access to care, and supporting private practices and DSOs as they evolve toward more integrated, health-focused models.

Dr. Bob Hinkle

Senior Clinical Advisor - Dental Division

Dr. Hinkle is a board certified oral and maxillofacial surgeon with 40 years of experience. He will act as a key team member supporting product education and training for dentists and dental specialists. Throughout his career, Dr. Hinkle has been invested in clinical research and the education of fellow dentists, dental specialists and oral and maxillofacial surgery residents. He has authored multiple professional articles and presented nationally and internationally on advanced oral surgery and dental implant techniques. Dr. Hinkle was an early adopter of a narcotic-free, multimodal pain management philosophy to ensure a safe pain-free post-operative experience for his patients.

James Cantrell

Operations Manager - Dental Division

James “Jamie” Cantrell is a healthcare executive with extensive experience in operations, business development, and organizational growth across the dental, medical device, and healthcare industries. Throughout his career, Jamie has focused on building high-performing teams, developing strategic partnerships, and implementing operational processes that improve efficiency, customer satisfaction, and business performance. His expertise includes market development, contract negotiations, customer engagement, operational analytics, and growth strategy execution.

Jamie has also played a key role in the introduction and adoption of innovative healthcare technologies, working closely with clinical leaders and industry stakeholders to develop evaluation programs, performance reporting systems, and data-driven initiatives that support better outcomes and informed decision-making.

Known for his collaborative leadership style and practical approach to problem-solving, Jamie is passionate about helping organizations leverage innovation, analytics, and operational excellence to achieve sustainable growth.

Ready to take the next step?

Have questions about Endura-KT? Explore the details or connect with our team to learn more.